Full Press Release Details
| Contacts: | ||
| Investor Relations | Media Relations | |
| Kristy Moser | Ventura Olvera | |
| Kristine.moser@petco.com | Ventura.olvera@petco.com |
FOR IMMEDIATE RELEASE: March 8, 2022
Petco Health + Wellness Company, Inc. Reports Record Year of Revenue and Profitability, Issues 2022 Guidance
San Diego, March 8, 2022 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today
released its financial results for fourth quarter and fiscal year 2021 ended January 29, 2022.
In the fourth quarter of 2021, Petco delivered net revenue of
$1.5 billion, up 13 percent versus prior year. Net income improved by $35.2 million from prior year to $29.0 million or $0.11 per share. Adjusted Net Income1 for the fourth
quarter increased $38.2 million to $75.1 million or $0.28 per share, up $0.11 or 65 percent3 from prior year, while Adjusted
EBITDA1 increased by $23.6 million or 16 percent2 from prior year to $172.2 million.
Net revenue for full year 2021 increased 18 percent or $886.9 million to $5.8 billion. Net income improved by $190.9 million from prior year to
$164.4 million or $0.62 per share. Adjusted Net Income1 for the year increased $183.0 million from prior year to $241.1 million or $0.91 per share, while Adjusted EBITDA1 increased by $107.1 million or 22 percent2 from prior year to $591.5 million.
Our results for the quarter and full year demonstrate that our focus on long-term, sustainable growth, powered by continued delivery against our strategic growth
opportunities, is working, said Ron Coughlin, Chairman and CEO of Petco. We enter this fiscal year as a stronger company than ever. Our category remains strong and resilient; our competitive moats are deepening, and our world-class team
is executing to deliver purpose driven performance. With an integrated omnichannel infrastructure, robust services offering including 197 veterinary hospitals, and millions of net new customers, we re well positioned to drive enhanced long-term
Additionally, total debt remained roughly flat throughout 2021 at $1.7 billion with Net Debt1 improving $72.9 million to $1.5 billion driven by net cash flow from operations of $358.2 million and Free Cash Flow1 of
$119.1 million, up 33 percent and 9 percent, respectively, from fiscal year 2020. Throughout 2021, Net Debt1 / Trailing Twelve Month Adjusted EBITDA1 decreased 22 percent or 0.7x to 2.5x driven by Free Cash Flow1 generation and growth in Adjusted EBITDA1.
Fiscal Q4 2021 Highlights:
Comparisons are fourth quarter of 2021 ended January 29, 2022 versus fourth quarter of 2020 ended January 30, 2021 unless otherwise noted
Fiscal Year 2021 Highlights:
fiscal year of 2021 ended January 29, 2022 versus fiscal year of 2020 ended January 30, 2021 unless otherwise noted
Fiscal 2022 Guidance:
The following guidance as of March 8, 2022 reflects the company s expectations for fiscal year 2022.
| Metric | Current Guidance | |||
| Net Revenue | $ | 6.15 - $6.25 billion | ||
| Adjusted EBITDA 3 | $ | 630 - $645 million | ||
| Adjusted EPS 3 | $ | 0.97 - $1.00 | ||
| Capital Expenditures | $ | 275 - $325 million |
Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally
consistent. Adjusted EPS guidance assumes approximately $76 million of interest expense, a 26 percent tax rate and a 267 million weighted average diluted share count.
Earnings Conference Call Webcast Information:
The company will host an earnings conference call on March 8, 2022 at 8:30 AM Eastern Time to discuss Petco s financial results. The conference call will be
accessible through live webcast. Interested investors and other individuals can access the webcast, earnings release, earnings presentation, and infographic via the company s investor relations page at ir.petco.com. A replay of the webcast will
be archived on the company s investor relations page through March 22, 2022 at approximately 5:00 PM Eastern Time.
About Petco, The Health + Wellness
Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. Since our founding
in 1965, we ve been striving to set new standards in pet care, delivering comprehensive wellness solutions through our products and services, and creating communities that deepen the pet-pet parent bond.
We operate more than 1,500 Petco locations across the U.S., Mexico and Puerto Rico, including a growing network of more than 150 in-store veterinary hospitals, and offer a complete online resource for pet
health and wellness at petco.com and on the Petco app. In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal
welfare groups across the country and, through in-store adoption events, we ve helped find homes for more than 6.5 million animals.
Forward-Looking Statements:
This earnings release contains
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended, concerning expectations, beliefs plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our
fiscal year 2022 guidance, our growth plans, and execution on our transformation initiatives. Such forward-looking statements can generally be identified by the use of forward-looking terms such as believes, expects,
may, intends, will, shall, should, anticipates, opportunity, illustrative , or the negative thereof or other variations thereon or comparable terminology.
Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized.
Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All
forward-looking statements are based on expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are
outside the control of Petco. Forward- looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the
forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and
e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks
arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate including
inflation; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a privacy
or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our
ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine), health crises,
and pandemics, including the potential effects that the ongoing COVID-19 pandemic and/or corresponding macroeconomic uncertainty could have on our financial position, results of operations and cash flows;
(xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate
portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; and (xx) the other risks, uncertainties and other factors identified under Risk Factors and elsewhere
in Petco s Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.
Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are
made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.
PETCO HEALTH AND WELLNESS COMPANY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
thousands, except per share amounts)
(Unaudited and subject to reclassification)
| 13 Weeks Ended | 52 Weeks Ended | |||||||||||||||||||||||
| January 29, 2022 | January 30, 2021 | Percent Change | January 29, 2022 | January 30, 2021 | Percent Change | |||||||||||||||||||
| Net sales | $ | 1,514,357 | $ | 1,337,713 | 13 | % | $ | 5,807,149 | $ | 4,920,202 | 18 | % | ||||||||||||
| Cost of sales | 878,851 | 768,448 | 14 | % | 3,380,539 | 2,813,464 | 20 | % | ||||||||||||||||
| Gross profit | 635,506 | 569,265 | 12 | % | 2,426,610 | 2,106,738 | 15 | % | ||||||||||||||||
| Selling, general and administrative expenses | 552,601 | 502,290 | 10 | % | 2,160,539 | 1,912,314 | 13 | % | ||||||||||||||||
| Operating income | 82,905 | 66,975 | 24 | % | 266,071 | 194,424 | 37 | % | ||||||||||||||||
| Interest income | (9 | ) | (321 | ) | (97 | %) | (62 | ) | (653 | ) | (91 | %) | ||||||||||||
| Interest expense | 18,893 | 49,987 | (62 | %) | 77,397 | 219,083 | (65 | %) | ||||||||||||||||
| Loss on extinguishment and modification of debt | 17,549 | (100 | %) | 20,838 | 17,549 | 19 | % | |||||||||||||||||
| Other non-operating loss (income) | 30,437 | N/M | (34,497 | ) | N/M | |||||||||||||||||||
| Income (loss) before income taxes and income from equity method investees | 33,584 | (240 | ) | N/M | 202,395 | (41,555 | ) | N/M | ||||||||||||||||
| Income tax expense (benefit) | 9,689 | 10,200 | (5 | %) | 53,473 | (3,337 | ) | N/M | ||||||||||||||||
| Income from equity method investees | (3,393 | ) | (3,530 | ) | (4 | %) | (10,883 | ) | (6,482 | ) | 68 | % | ||||||||||||
| Net income (loss) | 27,288 | (6,910 | ) | N/M | 159,805 | (31,736 | ) | N/M | ||||||||||||||||
| Net loss attributable to noncontrolling interest | (1,706 | ) | (751 | ) | 127 | % | (4,612 | ) | (5,253 | ) | (12 | %) | ||||||||||||
| Net income (loss) attributable to Class A and B-1 common stockholders | $ | 28,994 | $ | (6,159 | ) | N/M | $ | 164,417 | $ | (26,483 | ) | N/M | ||||||||||||
| Net income (loss) per Class A and B-1 common share: | ||||||||||||||||||||||||
| Basic | $ | 0.11 | $ | (0.03 | ) | N/M | $ | 0.62 | $ | (0.13 | ) | N/M | ||||||||||||
| Diluted | $ | 0.11 | $ | (0.03 | ) | N/M | $ | 0.62 | $ | (0.13 | ) | N/M | ||||||||||||
| Weighted average shares used in computing net income (loss) per Class A and B-1 common share: | ||||||||||||||||||||||||
| Basic | 264,384 | 215,687 | 23 | % | 264,261 | 210,683 | 25 | % | ||||||||||||||||
| Diluted | 265,785 | 215,687 | 23 | % | 265,338 | 210,683 | 26 | % |
PETCO HEALTH AND WELLNESS COMPANY, INC.
CONSOLIDATED BALANCE SHEETS
except per share amounts)
(Unaudited and subject to reclassification)
| January 29, 2022 | January 30, 2021 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 211,602 | $ | 111,402 | ||||
| Receivables, less allowance for credit losses 1 | 55,618 | 41,827 | ||||||
| Merchandise inventories, net | 675,111 | 538,675 | ||||||
| Prepaid expenses | 42,355 | 40,032 | ||||||
| Other current assets | 86,091 | 45,613 | ||||||
| Total current assets | 1,070,777 | 777,549 | ||||||
| Fixed assets, net | 726,922 | 627,547 | ||||||
| Operating lease right-of-use assets | 1,338,465 | 1,328,108 | ||||||
| Goodwill | 2,183,991 | 2,179,310 | ||||||
| Trade name | 1,025,000 | 1,025,000 | ||||||
| Other long-term assets | 152,786 | 138,188 | ||||||
| Total assets | $ | 6,497,941 | $ | 6,075,702 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and book overdrafts | $ | 403,976 | $ | 339,485 | ||||
| Accrued salaries and employee benefits | 150,630 | 129,484 | ||||||
| Accrued expenses and other liabilities | 210,872 | 145,846 | ||||||
| Current portion of operating lease liabilities | 265,897 | 258,289 | ||||||
| Current portion of long-term debt and other lease liabilities | 21,764 | 2,203 | ||||||
| Total current liabilities | 1,053,139 | 875,307 | ||||||
| Senior secured credit facilities, net, excluding current portion | 1,640,390 | 1,646,281 | ||||||
| Operating lease liabilities, excluding current portion | 1,096,133 | 1,083,575 | ||||||
| Deferred taxes, net | 318,355 | 280,920 | ||||||
| Other long-term liabilities | 134,105 | 134,354 | ||||||
| Total liabilities | 4,242,122 | 4,020,437 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders equity: | ||||||||
| Class A common stock 2 | 227 | 226 | ||||||
| Class B-1 common stock 3 | 38 | 38 | ||||||
| Class B-2 common stock 4 | ||||||||
| Preferred stock 5 | ||||||||
| Additional paid-in-capital | 2,133,821 | 2,092,110 | ||||||
| Retained earnings (accumulated deficit) | 142,166 | (22,251 | ) | |||||
| Accumulated other comprehensive loss | (2,238 | ) | (1,275 | ) | ||||
| Total stockholders equity | 2,274,014 | 2,068,848 | ||||||
| Noncontrolling interest | (18,195 | ) | (13,583 | ) | ||||
| Total equity | 2,255,819 | 2,055,265 | ||||||
| Total liabilities and equity | $ | 6,497,941 | $ | 6,075,702 |
PETCO HEALTH AND WELLNESS COMPANY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited and subject to
| 52 Weeks Ended | ||||||||
| January 29, 2022 | January 30, 2021 | |||||||
| Cash flows from operating activities: | ||||||||
| Net income (loss) | $ | 159,805 | $ | (31,736 | ) | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 172,431 | 174,836 | ||||||
| Amortization of debt discounts and issuance costs | 5,796 | 24,237 | ||||||
| Provision for deferred taxes | 37,741 | 25,548 | ||||||
| Equity-based compensation | 49,265 | 12,915 | ||||||
| Impairments, write-offs and losses on sale of fixed and other assets | 10,918 | 15,606 | ||||||
| Loss on extinguishment and modification of debt | 20,838 | 17,549 | ||||||
| Income from equity method investees | (10,883 | ) | (6,482 | ) | ||||
| Amounts reclassified out of accumulated other comprehensive income | 10,793 | |||||||
| Change in contingent consideration obligation | (398 | ) | ||||||
| Non-cash operating lease costs | 422,465 | 430,359 | ||||||
| Other non-operating income | (34,497 | ) | ||||||
| Changes in assets and liabilities: | ||||||||
| Receivables | (13,791 | ) | (10,311 | ) | ||||
| Merchandise inventories | (136,404 | ) | (60,635 | ) | ||||
| Prepaid expenses and other assets | (17,664 | ) | (13,842 | ) | ||||
| Accounts payable and book overdrafts | 71,775 | 46,303 | ||||||
| Accrued salaries and employee benefits | 10,679 | 34,295 | ||||||
| Accrued expenses and other liabilities | 42,899 | (28,289 | ) | |||||
| Operating lease liabilities | (418,210 | ) | (399,557 | ) | ||||
| Other long-term liabilities | (14,948 | ) | 27,424 | |||||
| Net cash provided by operating activities | 358,215 | 268,615 | ||||||
| Cash flows from investing activities: | ||||||||
| Cash paid for fixed assets | (239,110 | ) | (159,560 | ) | ||||
| Cash paid for acquisitions, net of cash acquired | (4,334 | ) | ||||||
| Cash paid for investments | (1,000 | ) | ||||||
| Proceeds from investments | 6,135 | 73 | ||||||
| Proceeds from sale of assets | 226 | 3,302 | ||||||
| Net cash used in investing activities | (237,083 | ) | (157,185 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Borrowings under long-term debt agreements | 1,700,000 | 476,000 | ||||||
| Repayments of long-term debt | (1,690,861 | ) | (1,554,890 | ) | ||||
| Debt refinancing costs | (24,665 | ) | ||||||
| Payments for finance lease liabilities | (3,564 | ) | (3,404 | ) | ||||
| Proceeds from employee stock purchase plan | 4,185 | |||||||
| Tax withholdings on stock-based awards | (33 | ) | ||||||
| Proceeds from initial public offering, net of issuance costs | 936,041 | |||||||
| Repurchase of equity | (105 | ) | ||||||
| Payment of contingent consideration | (250 | ) | ||||||
| Payment of offering costs | (3,844 | ) | ||||||
| Net cash used in financing activities | (18,782 | ) | (146,608 | ) | ||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 102,350 | (35,178 | ) | |||||
| Cash, cash equivalents and restricted cash at beginning of period | 119,540 | 154,718 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 221,890 | $ | 119,540 |
NON-GAAP FINANCIAL MEASURES
The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings
release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial
information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release.
The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.
Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA
including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission s ( SEC ) rules because it excludes certain amounts
included in net income (loss) calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the
comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco s core operating performance as well as the ability to make a more informed assessment of such operating performance as
compared with that of the prior period.
Please see the company s Annual Report on Form 10-K for the fiscal year ended
January 30, 2021 filed with the SEC on April 5, 2021 for additional information on Adjusted EBITDA. The tables below reflect the calculation of Adjusted EBITDA for the thirteen and fifty-two weeks
ended January 29, 2022 compared to the thirteen and fifty-two weeks ended January 30, 2021, respectively.
| (dollars in thousands) | 13 Weeks Ended | 52 Weeks Ended | ||||||||||||||
| Reconciliation of Net Income (Loss) Attributable to Class A and B-1 Common Stockholders to Adjusted EBITDA | January 29, 2022 | January 30, 2021 | January 29, 2022 | January 30, 2021 | ||||||||||||
| Net income (loss) attributable to Class A and B-1 common stockholders | $ | 28,994 | $ | (6,159 | ) | $ | 164,417 | $ | (26,483 | ) | ||||||
| Add (deduct): | ||||||||||||||||
| Interest expense, net | 18,884 | 49,666 | 77,335 | 218,430 | ||||||||||||
| Income tax expense (benefit) | 9,689 | 10,200 | 53,473 | (3,337 | ) | |||||||||||
| Depreciation and amortization | 46,794 | 45,875 | 172,431 | 174,836 | ||||||||||||
| Income from equity method investees | (3,393 | ) | (3,530 | ) | (10,883 | ) | (6,482 | ) | ||||||||
| Loss on debt extinguishment and modification | 17,549 | 20,838 | 17,549 | |||||||||||||
| Asset impairments and write offs | 5,000 | 7,955 | 10,918 | 15,606 | ||||||||||||
| Equity-based compensation | 12,774 | 5,451 | 49,265 | 12,915 | ||||||||||||
| Other non-operating loss (income) | 30,437 | (34,497 | ) | |||||||||||||
| Mexico joint venture EBITDA (1) | 8,314 | 6,655 | 26,837 | 19,074 | ||||||||||||
| Store pre-opening expenses | 3,026 | 2,218 | 14,765 | 9,228 | ||||||||||||
| Store closing expenses | 1,699 | 1,835 | 5,028 | 7,782 | ||||||||||||
| Non-cash occupancy-related costs (2) | 2,550 | 2,151 | 8,114 | 19,240 | ||||||||||||
| Non-recurring costs (3) | 7,382 | 8,733 | 33,437 | 25,990 | ||||||||||||
| Adjusted EBITDA | $ | 172,150 | $ | 148,599 | $ | 591,478 | $ | 484,348 | ||||||||
| Net sales | $ | 1,514,357 | $ | 1,337,713 | $ | 5,807,149 | $ | 4,920,202 | ||||||||
| Net margin (4) | 1.9 | % | (0.5 | %) | 2.8 | % | (0.5 | %) | ||||||||
| Adjusted EBITDA Margin | 11.4 | % | 11.1 | % | 10.2 | % | 9.8 | % |
Adjusted Net Income and Adjusted EPS
Adjusted Net Income and Adjusted diluted earnings per share attributable to Petco common stockholders (Adjusted EPS) are considered
non-GAAP financial measures under the SEC s rules because they exclude certain amounts included in the net income (loss) attributable to Petco common stockholders and diluted earnings per share
attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period
performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco s core earnings performance as well as the ability to make a more informed
assessment of such earnings performance with that of the prior period.
The tables below reflect the calculation of Adjusted Net Income (Loss) and Adjusted EPS for
the thirteen and fifty-two weeks ended January 29, 2022 compared to the thirteen and fifty-two weeks prior year quarter ended January 30, 2021, respectively.
| 13 Weeks Ended | ||||||||||||||||
| (in thousands, except per share amounts) | January 29, 2022 | January 30, 2021 | ||||||||||||||
| Reconciliation of Diluted EPS to Adjusted EPS | Amount | Per share | Amount | Per share | ||||||||||||
| Net income (loss) attributable to common stockholders / diluted EPS | $ | 28,994 | $ | 0.11 | $ | (6,159 | ) | $ | (0.03 | ) | ||||||
| Add (deduct): | ||||||||||||||||
| Income tax expense | 9,689 | 0.04 | 10,200 | 0.05 | ||||||||||||
| Loss on debt extinguishment and modification | 17,549 | 0.08 | ||||||||||||||
| Asset impairments and write offs | 5,000 | 0.02 | 7,955 | 0.03 | ||||||||||||
| Equity-based compensation | 12,774 | 0.05 | 5,451 | 0.03 | ||||||||||||
| Other non-operating loss | 30,437 | 0.11 | ||||||||||||||
| Store pre-opening expenses | 3,026 | 0.01 | 2,218 | 0.01 | ||||||||||||
| Store closing expenses | 1,699 | 0.01 | 1,835 | 0.01 | ||||||||||||
| Non-cash occupancy-related costs (2) | 2,550 | 0.01 | 2,151 | 0.01 | ||||||||||||
| Non-recurring costs (3) | 7,382 | 0.02 | 8,733 | 0.04 | ||||||||||||
| Adjusted pre-tax income / diluted earnings per share | $ | 101,551 | $ | 0.38 | $ | 49,933 | $ | 0.23 | ||||||||
| Income tax expense at 26% normalized tax rate | 26,403 | 0.10 | 12,983 | 0.06 | ||||||||||||
| Adjusted Net Income / Adjusted EPS | $ | 75,148 | $ | 0.28 | $ | 36,950 | $ | 0.17 |
| 52 Weeks Ended | ||||||||||||||||
| (in thousands, except per share amounts) | January 29, 2022 | January 30, 2021 | ||||||||||||||
| Reconciliation of Diluted EPS to Adjusted EPS | Amount | Per share | Amount | Per share | ||||||||||||
| Net income (loss) attributable to common stockholders / diluted EPS | $ | 164,417 | $ | 0.62 | $ | (26,483 | ) | $ | (0.13 | ) | ||||||
| Add (deduct): | ||||||||||||||||
| Income tax expense (benefit) | 53,473 | 0.20 | (3,337 | ) | (0.02 | ) | ||||||||||
| Loss on debt extinguishment and modification | 20,838 | 0.08 | 17,549 | 0.08 | ||||||||||||
| Asset impairments and write offs | 10,918 | 0.04 | 15,606 | 0.07 | ||||||||||||
| Equity-based compensation | 49,265 | 0.19 | 12,915 | 0.06 | ||||||||||||
| Other non-operating income | (34,497 | ) | (0.13 | ) | ||||||||||||
| Store pre-opening expenses | 14,765 | 0.06 | 9,228 | 0.05 | ||||||||||||
| Store closing expenses | 5,028 | 0.02 | 7,782 | 0.04 | ||||||||||||
| Non-cash occupancy-related costs (2) | 8,114 | 0.03 | 19,240 | 0.09 | ||||||||||||
| Non-recurring costs (3) | 33,437 | 0.12 | 25,990 | 0.13 | ||||||||||||
| Adjusted pre-tax income / diluted earnings per share | $ | 325,758 | $ | 1.23 | $ | 78,490 | $ | 0.37 | ||||||||
| Income tax expense at 26% normalized tax rate | 84,697 | 0.32 | 20,407 | 0.09 | ||||||||||||
| Adjusted Net Income / Adjusted EPS | $ | 241,061 | $ | 0.91 | $ | 58,083 | $ | 0.28 |
Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to
generate additional cash from business operations, is an important financial measure for use in evaluating the company s financial performance.
The table below reflects the calculation of Free Cash Flow for the thirteen and fifty-two weeks ended January 29, 2022
compared to the thirteen and fifty-two weeks ended January 30, 2021, respectively.
| 13 Weeks Ended | 52 Weeks Ended | |||||||||||||||
| (in thousands) | January 29, 2022 | January 30, 2021 | January 29, 2022 | January 30, 2021 | ||||||||||||
| Net cash provided by operating activities | $ | 69,771 | $ | 67,135 | $ | 358,215 | $ | 268,615 | ||||||||
| Cash paid for fixed assets | (74,780 | ) | (63,271 | ) | (239,110 | ) | (159,560 | ) | ||||||||
| Free Cash Flow | $ | (5,009 | ) | $ | 3,864 | $ | 119,105 | $ | 109,055 |